File(s) not publicly available
Are there specific translational challenges in regenerative medicine? Lessons from other fields
journal contribution
posted on 2023-06-09, 00:44 authored by John Gardner, Alex Faulkner, Aurelie Mahalatchimy, Andrew WebsterThere is concern that translation ‘from bench to bedside’ within regenerative medicine (RM) will fail to materialize, or will be dismally slow, due to various challenges arising from the highly novel and disruptive nature of RM. In this article, we provide a summary of these challenges, and we critically engage with the notion that such challenges are specific to RM. It is important, we argue, not to overstate the exceptional nature of RM, as valuable lessons can be learned from elsewhere in medicine. Using several examples of technology adoption, we suggest that emerging RM products and procedures will have to work hard to find or create an adoption space if translation into the clinic is to be successful.
Funding
Regenerative medicine and its potential for development and diffusion: an analysis of emergent value systems and health service readiness; G1398; ESRC-ECONOMIC & SOCIAL RESEARCH COUNCIL; R15474 - ES/L002779/1
History
Publication status
- Published
Journal
Regenerative MedicineISSN
1746-0751Publisher
Future MedicineExternal DOI
Issue
7Volume
10Page range
885-895Department affiliated with
- International Relations Publications
Full text available
- No
Peer reviewed?
- Yes
Legacy Posted Date
2016-04-01Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC